Understanding of the patho-mechanisms following SARS-CoV-2 infection is critical to repurpose the available FDA approved drugs for immediate therapeutic interventions toward COVID-19. Moreover, preventive strategies may help to manage the disease better.
Here in this study, we have applied a systems biology approach to unravel key pathomechanisms of COVID-19 to great details and proposed potential therapeutic and preventive strategies to tackle this deadly disease. The findings from this study would guide the initiation of clinical trials. Pre print is available in the following link.